Moreover, BET bromodomain inhibitor JQ1, in combination with panobinostat, showed strong antitumor effects in NB: it blocked BRD3 and BRD4 activity, preventing LIN28B transcriptional activation [73]. This evidence concerns the gene LIN28B and neuroblastoma.